UPMC HAMOT
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $658K
- Transactions
- 406
- Companies
- 40
- Average per transaction
- $1,620
Who reported the payments
| Novartis | $142,004 |
| Janssen Research & Development, LLC | $104,631 |
| Angiodynamics, Inc. | $65,934 |
| Contego Medical, Inc | $42,519 |
| Stryker | $31,960 |
| Boston Scientific | $25,670 |
| Pfizer | $22,000 |
| Johnson & Johnson | $18,500 |
| Abbott | $16,386 |
| Medical Device Business Services, Inc. | $12,042 |
| AstraZeneca | $12,000 |
| Edwards Lifesciences | $10,000 |
| Bio-rad Laboratories, Inc. | $9,494 |
| Vifor (international) Ltd. | $9,000 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $8,250 |
| KCI USA, Inc. | $8,120 |
| UCB, Inc. | $8,000 |
| Boehringer Ingelheim | $6,750 |
| ZOLL Circulation Inc | $6,721 |
| Genentech USA, Inc. | $6,000 |
| E.r. Squibb & Sons, L.L.C. | $5,250 |
| CSL Behring | $5,250 |
| Merck | $5,050 |
| Portola Pharmaceuticals, LLC | $4,500 |
| GSK | $4,450 |
| Sanofi Pasteur Inc. | $3,750 |
| AbbVie | $3,250 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $3,000 |
| Argenx US, Inc. | $3,000 |
| Sanofi-aventis U.S. LLC | $2,500 |
| Cochlear Americas | $2,350 |
| Neurocrine Biosciences, Inc. | $2,250 |
| Biogen | $2,250 |
| Penumbra, Inc. | $2,250 |
| Amgen | $2,250 |
| Lilly USA, LLC | $2,250 |
| Amarin Pharma, Inc. | $2,250 |
| Zimmer Biomet | $2,008 |
| Tanabe Pharma America, Inc. | $2,000 |
| Teva Pharmaceuticals USA, Inc. | $1,750 |